Cholangiocarcinoma

Cholangiocarcinoma is a highly lethal biliary epithelial tumor that is rare in the general population but has increased rates in patients with primary sclerosing cholangitis (PSC). It is heterogenous, and management varies by location. No effective prevention exists, and screening is likely only feasible in PSC. Patients often present in an advanced state with jaundice, weight loss, and cholestatic liver enzymes . Diagnosis requires imaging with magnetic resonance cholangiopancreatography , laboratory testing, and endoscopic retrograde cholangiopancreatography . Potentially curative options include resection and liver transplant with neoadjuvant or adjuvant chemoradiation . Chemotherapy, radiation, and locoregional therapy provide some survival benefit in unresectable disease.